John Gnann to Acyclovir
This is a "connection" page, showing publications John Gnann has written about Acyclovir.
Connection Strength
1.651
-
Herpes Simplex Encephalitis: Lack of Clinical Benefit of Long-term Valacyclovir Therapy. Clin Infect Dis. 2015 Sep 01; 61(5):683-91.
Score: 0.489
-
Herpes zoster: risk categories for persistent pain. J Infect Dis. 1999 Jan; 179(1):9-15.
Score: 0.157
-
Sorivudine versus acyclovir for treatment of dermatomal herpes zoster in human immunodeficiency virus-infected patients: results from a randomized, controlled clinical trial. Collaborative Antiviral Study Group/AIDS Clinical Trials Group, Herpes Zoster Study Group. Antimicrob Agents Chemother. 1998 May; 42(5):1139-45.
Score: 0.150
-
Kaposi's varicelliform eruption. Intern Emerg Med. 2014 Feb; 9(1):101-2.
Score: 0.109
-
Acyclovir: a decade later. N Engl J Med. 1992 Sep 10; 327(11):782-9.
Score: 0.102
-
Varicella-zoster virus: Prevention through vaccination. Clin Obstet Gynecol. 2012 Jun; 55(2):560-70.
Score: 0.100
-
Natural history and treatment of varicella-zoster in high-risk populations. J Hosp Infect. 1991 Jun; 18 Suppl A:317-29.
Score: 0.093
-
Acyclovir: the past ten years. Adv Exp Med Biol. 1990; 278:243-53.
Score: 0.084
-
The incidence and severity of herpes simplex encephalitis in Sweden, 1990-2001. Clin Infect Dis. 2007 Oct 01; 45(7):881-2.
Score: 0.072
-
Acyclovir: mechanism of action, pharmacokinetics, safety and clinical applications. Pharmacotherapy. 1983 Sep-Oct; 3(5):275-83.
Score: 0.054
-
Therapeutic approaches to the management of herpes zoster. Adv Exp Med Biol. 1999; 458:159-65.
Score: 0.039
-
Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Ann Intern Med. 1996 Sep 01; 125(5):376-83.
Score: 0.033
-
Unique clinical trial design: combination acyclovir plus prednisone therapy of localized zoster in the normal host. Antiviral Res. 1996 Jan; 29(1):67-8.
Score: 0.032
-
Herpes zoster in patients with human immunodeficiency virus infection--an ever-expanding spectrum of disease. Clin Infect Dis. 1995 Oct; 21(4):989-90.
Score: 0.031
-
New antivirals with activity against varicella-zoster virus. Ann Neurol. 1994; 35 Suppl:S69-72.
Score: 0.028
-
Disseminated herpes zoster in the immunocompromised host: a comparative trial of acyclovir and vidarabine. The NIAID Collaborative Antiviral Study Group. J Infect Dis. 1992 Mar; 165(3):450-5.
Score: 0.025
-
Intravenous acyclovir therapy of first episodes of genital herpes: a multicenter double-blind, placebo-controlled trial. Am J Med. 1988 Sep; 85(3):301-6.
Score: 0.019
-
Recommendations for the management of herpes zoster. Clin Infect Dis. 2007 Jan 01; 44 Suppl 1:S1-26.
Score: 0.017
-
A collaborative study of patient-initiated treatment of recurrent genital herpes with topical acyclovir or placebo. J Infect Dis. 1984 Jul; 150(1):1-6.
Score: 0.014